SHTYLLA BRUNILDA (Chief Business Officer) sold 47.3% of their position (11.61K shares) of SUTRO BIOPHARMA, INC. on the open market
Open‑market sale worth $53.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/28/2023ACC: 0001209191-23-047512
Officer· Chief Business Officer
Since Mar 2023
-11.61K
Net shares
Net seller
$53.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.61K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.61K
Price / share
$4.59
Trade value
$53.28K
% of position
47.3%
8/25/2023
24.54K→12.93K
Total
Net shares
−11.61K
Net value
-$53.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2023 | S · Sale | −11.61K | $4.59 | $53.28K | 47.3% | 24.54K | 12.93K |
| Total | −11.61K | -$53.28K | ||||||
Derivative Transactions0
No derivative transactions reported